Global Quality Assurance Model for Radiation Therapy Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Quality Assurance Model for Radiation Therapy Market Research Report 2024
The Quality Assurance Model for Radiation Therapy helps radiation physicists verify beam alignment, treatment planning systems, dose alignment, and patient positioning, and it also provides a graphical representation of dose volumes. Advanced models enable the creation of 3D tumor representations and patient anatomy, and perform patient-specific quality checks on respiratory-gated radiation therapy sessions.
According to MRAResearch’s new survey, global Quality Assurance Model for Radiation Therapy market is projected to reach US$ 35 million in 2033, increasing from US$ 26 million in 2022, with the CAGR of 4.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Quality Assurance Model for Radiation Therapy market research.
Rising prevalence of malignancies and colon cancer, patients' pursuit of advanced cancer therapies are the key factors driving the increase in radiotherapy quality assurance models market revenue.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Quality Assurance Model for Radiation Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Fluke Biomedical
IBA Dosimetry
Modus Medical Devices
PTW Freiburg GmbH
Standard lmaging
Sun Nuclear Corporation
The Phantom Laboratory
Gammex
Gold Standard Phantoms
Shanghai Radiation Therapy Quality Control Center
Segment by Type
Low Dose Radiation
High Dose Radiation
Prostate Cancer
Breast Cancer
Lung Cancer
Colorectal Cancer
Head And Neck Cancer
Skin Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Quality Assurance Model for Radiation Therapy report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source
According to MRAResearch’s new survey, global Quality Assurance Model for Radiation Therapy market is projected to reach US$ 35 million in 2033, increasing from US$ 26 million in 2022, with the CAGR of 4.4% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Quality Assurance Model for Radiation Therapy market research.
Rising prevalence of malignancies and colon cancer, patients' pursuit of advanced cancer therapies are the key factors driving the increase in radiotherapy quality assurance models market revenue.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Quality Assurance Model for Radiation Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Fluke Biomedical
IBA Dosimetry
Modus Medical Devices
PTW Freiburg GmbH
Standard lmaging
Sun Nuclear Corporation
The Phantom Laboratory
Gammex
Gold Standard Phantoms
Shanghai Radiation Therapy Quality Control Center
Segment by Type
Low Dose Radiation
High Dose Radiation
Segment by Application
Prostate Cancer
Breast Cancer
Lung Cancer
Colorectal Cancer
Head And Neck Cancer
Skin Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Quality Assurance Model for Radiation Therapy report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source